Evidence map›Paper›PMID 31828717›Full record

ArticleMolecular imaging and biology2020

In Response to Letter from Fregonara et al. 2019.

Richard Nicholas, David Brooks, David Owen

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Anatomy ofEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  3. 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis.European journal of nuclear medicine and molecular imaging · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Richard NicholasDivision of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. r.nicholas@imperial.ac.uk.ORCID 0000-0003-0414-1225
David BrooksDivision of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
David OwenDivision of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.

Funding

Medical Research Council MR/N008219/1Medical Research Council MR/T031891/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gray MatterMultiple SclerosisCarbazolesHumansPurinesCarbazolesGE-180N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamidePurines

Identifiers

PMID31828717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.